Related Experiment Video
Updated: Mar 22, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
PLATELET INDICES AND LIVER FIBROSIS EVALUATION IN CHRONIC HEPATITIS C
Insights
Platelet indices like mean platelet volume and platelet distribution width can indicate advanced liver fibrosis in chronic hepatitis C patients. These findings suggest their utility in assessing liver fibrosis severity non-invasively.
Area of Science:
- Hepatology
- Hematology
- Diagnostic Biomarkers
Background:
- Chronic hepatitis C is a significant cause of liver fibrosis.
- Platelet indices have emerged as potential indicators of liver fibrosis severity.
- Non-invasive methods for assessing liver fibrosis are crucial for patient management.
Purpose of the Study:
- To investigate the correlation between platelet indices and liver fibrosis stages.
- To evaluate the diagnostic value of mean platelet volume (MPV), platelet large cell ratio (P-LCR), and platelet distribution width (PDW) in chronic hepatitis C.
- To compare these indices with liver fibrosis assessment by transient elastography.
Main Methods:
- Prospective enrollment of 139 patients with chronic hepatitis C.
- Simultaneous assessment of complete blood count parameters and liver fibrosis using transient elastography.
- Statistical analysis comparing platelet indices (MPV, P-LCR, PDW) with fibrosis stages.
Main Results:
- Patients with advanced liver fibrosis showed significantly increased MPV (p < 0.002), P-LCR (P < 0.0001), and PDW (P = 0.003) compared to those with mild/moderate fibrosis.
- A total of 139 patients were included, with 70.5% males and a mean age of 54.8 years.
- The study utilized SPSS 17.0 for statistical analysis, with P < 0.05 considered significant.
Conclusions:
- Elevated platelet indices are associated with advanced liver fibrosis in chronic hepatitis C.
- Platelet indices may serve as valuable non-invasive biomarkers for assessing liver fibrosis severity.
- Transient elastography is a reliable method for staging liver fibrosis in conjunction with platelet indices.
Unlabelled:
Recently, several studies have reported that the mean platelet volume and platelet distribution width may give information about liver fibrosis severity in chronic hepatitis C. The aim of the present study was to evaluate whether platelet indices correlate with hepatic fibrosis measured by transient elastography in patients with chronic hepatitis C.
Materials And Methods:
Patients with chronic hepatitis C were prospectively enrolled. Samples for complete blood count and routine biochemical parameters were collected and analyzed in the same day with liver fibrosis assessment by transient elastography. Mean platelet volume, platelet large cell ratio and platelet distribution width were compared with stages of liver fibrosis. Statistical analysis was carried out using SPSS 17.0 software. A P-value of less than 0.05 was considered statistically significant.
Results:
There were 139 patients with chronic hepatitis C (70.5% males, mean age 54.8 +/- 16.7 years). Compared with mild/moderate liver fibrosis patients, those with advanced liver fibrosis had an increased mean platelet volume (10.4 +/- 0.7 vs. 10.9 +/- 0.9, p < 0.002), platelet large cell ratio (28.5 +/- 5.3 vs. 32.5 +/- 7.2, P < 0.0001), and platelet distribution width (12.8 +/- 1.5 vs. 14.1 +/- 2.7, P = 0.003).
Conclusions:
Increased platelet indices were associated with advanced liver fibrosis stages evaluated by transient elastography in patients with chronic hepatitis C.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
06:09Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):